ID: ALA108576

Max Phase: Preclinical

Molecular Formula: C40H56N6O10S2

Molecular Weight: 845.05

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)O)NC(=O)[C@H](CCSC)NC=O

Standard InChI:  InChI=1S/C40H56N6O10S2/c1-25(2)20-30(37(51)45-32(39(53)54)21-26-12-8-6-9-13-26)43-36(50)29(17-19-58-5)42-34(48)23-31(44-35(49)28(41-24-47)16-18-57-4)38(52)46-33(40(55)56-3)22-27-14-10-7-11-15-27/h6-15,24-25,28-33H,16-23H2,1-5H3,(H,41,47)(H,42,48)(H,43,50)(H,44,49)(H,45,51)(H,46,52)(H,53,54)/t28-,29-,30-,31-,32-,33-/m0/s1

Standard InChI Key:  NWMQELCAXVIKMJ-FSJACQRISA-N

Associated Targets(Human)

Superoxide dismutase 173 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Lysozyme C 11 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 845.05Molecular Weight (Monoisotopic): 844.3499AlogP: 1.21#Rotatable Bonds: 27
Polar Surface Area: 238.20Molecular Species: ACIDHBA: 11HBD: 7
#RO5 Violations: 3HBA (Lipinski): 16HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.99CX Basic pKa: CX LogP: 1.88CX LogD: -1.28
Aromatic Rings: 2Heavy Atoms: 58QED Weighted: 0.05Np Likeness Score: -0.06

References

1. Cavicchioni G, Turchetti M, Spisani S..  (2001)  Biological activity in human neutrophils of di-tripeptides, analogues of the chemotactic fMLP.,  11  (24): [PMID:11720864] [10.1016/s0960-894x(01)00640-0]

Source